New study aims to ease suffering after stem cell transplants in vulnerable patients
NCT ID NCT03870750
First seen Jan 12, 2026 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This study tested two approaches—supportive and palliative care (focusing on symptom relief) and clinical management of other health problems (like heart or lung disease)—to see if they could improve quality of life and survival after a donor stem cell transplant. It included 458 older, weak, or frail patients with blood diseases. The goal was to find the best way to reduce suffering and improve outcomes after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Houston, Texas, 77030, United States
-
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, 44195, United States
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Northwell Health Cancer Institute
New Hyde Park, New York, 11042, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Stanford Cancer Institute Palo Alto
Palo Alto, California, 94304, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
-
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.